Cl. Chaffin et al., MODULATION OF GROWTH AXIS GENE-EXPRESSION BY IN-UTERO AND LACTATIONALEXPOSURE TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) IN THE WEANINGHOLTZMAN RAT, Endocrine, 5(2), 1996, pp. 129-134
While the in utero and lactational effects of 2,3,7,8-tetrachlorodiben
zo-p-dioxin (TCDD) on both male and female reproductive systems appear
to be severe, little is known about its effects on the developing gro
wth axis. The objective of th is study was to describe changes in grow
th axis gene expression that accompany exposure to TCDD during in uter
o and lactational development. Pregnant Holtzman rats were administere
d 1 mu g TCDD/kg maternal body weight or vehicle control on gestationa
l day 15 by gavage. Using ribonuclease protection assays, we compared
mRNA levels measured in 21-d-old female pups exposed to TCDD with leve
ls measured in control animals for the following genes: somatostatin,
growth hormone-releasing hormone (GHRH), hypothalamic and pituitary ga
lanin (GAL), growth hormone (GH), and insulin-like growth factor-I (IG
F-I). Serum CH concentrations measured by radioimmunoassay were signif
icantly increased, although GH mRNA levels were unchanged from control
s by TCDD exposure. Hypothalamic GAL mRNA was decreased in TCDD-treate
d animals, whereas pituitary GAL mRNA in TCDD-treated animals was not
altered. GHRH mRNA was increased in hypothalami from TCDD-exposed anim
als. IGF-I mRNA in the liver was decreased to 67% of controls. These d
ata indicate that the growth axis is sensitive to the effects of TCDD
delivered during critical periods of development. The alterations obse
rved in growth axis gene expression with exposure to TCDD add to the b
ody of data demonstrating a potent effect of this compound on the feta
l and neonatal endocrine system.